Rezolut Logo
Corporate Logo

Rezolut, LLC, a high-growth medical imaging business, is pleased to announce it has entered into a partnership agreement with CNY Diagnostic Imaging Associates, LLC, headquartered in Syracuse, NY.   

CNY Diagnostic Imaging Associates, LLC is a multimodality, all-digital radiology network in Central New York consisting of three imaging centers in Onondaga County. CNY provides mammography, MRI, CT, ultrasound, and other diagnostic imaging services. The practice was founded in 1979 in Syracuse, New York, by a team of experienced medical practitioners focused on providing prompt service to patients and their referring physicians in a modern and pleasant atmosphere.   

Over the years, CNY Diagnostic Imaging Associates, LLC developed a reputation for delivering patient-tailored, high-quality diagnostic imaging services. This dedication is supported by advanced diagnostic imaging technology and the skills and expertise of highly qualified and esteemed board-certified radiologists. 

Dr. Jin Kim, CEO of Rezolut, stated, "CNY embodies the same values and vision as Rezolut with a focus on providing superior patient care partnered with innovative technology to achieve the best health outcomes for the patients they serve. The team at CNY has built a strong radiology business by providing exceptional quality and by earning the trust of patients and physicians. Additionally, the partnership with CNY's radiologists will provide additional support, quality assurance and allows us to continue building a powerful Rezolut footprint in the Northeast."

"For 40-plus years, CNY Diagnostic Imaging has been driven by the fundamental mission to provide the highest quality radiology services and to deliver a care model that is patient and referrer centric. CNY is excited to partner with Rezolut because they share these values. We look forward to serving our community together for many years to come," said Dr. Patrick Lynch, Medical Director of CNY Diagnostic Imaging Associates, LLC. 

The acquisition increases Rezolut's number of outpatient imaging centers to 40 nationally, with 16 in the Northeast. The move demonstrates Rezolut's commitment to building an innovative, national, multi-modal platform that delivers high-quality patient service. 

About Rezolut, LLC

Rezolut is a national platform of diagnostic medical imaging services. With a focus on four key platforms, its mission is to provide and facilitate top-notch patient care, partnered with innovative technology, to achieve better health outcomes. To learn more about Rezolut, visit www.rezolut.com.

An innovative and award-winning crime prevention program is keeping construction sites safe from thieves in one of the fastest-growing areas of the country.

The Collier County Sheriff's Office Construction Site Watch Program recently was named the Outstanding Crime Prevention Program of the Year by the Florida Crime Prevention Association. Sheriff Kevin Rambosk created the program in November 2021 to allow deputies to work closely with contractors to monitor and protect at-risk equipment and materials.

"As our area continues to grow and prosper, we are committed to preventing crimes anywhere in the county - even those places that are still being built," Rambosk said. "The FCPA award recognizes the success of this program in identifying, preventing, investigating and minimizing construction site crime."

Through the Construction Site Watch Program deputies are preventing crimes with a combination of community engagement, data analysis and sophisticated tracking and monitoring technology.

Located in Southwest Florida, Collier County is seeing a surge in construction because of a high demand for housing, which also leads to more commercial building. Construction sites often are targeted by criminals because they're in remote locations, lack security and lighting, and usually have thousands of dollars of materials and equipment on hand.

The cost of materials has gone up, and supply-chain issues have created a higher demand, making construction sites even more attractive to thieves. 

With the Construction Site Watch Program, the Sheriff's Office partners with contractors to protect equipment. The program is simple and effective.

Contractors alert the Sheriff's Office when they have materials being delivered, or when they are leaving equipment on-site. They can send pictures and serial numbers of specific items they would like monitored.

CCSO's Real-Time Operations Center (ROC) compiles a watchlist of vulnerable locations. That list is then sent to deputies, who closely monitor these sites by visiting the locations daily. The ROC uses geo-fencing capabilities to accurately track site checks. 

If deputies discover that something is missing, they have the contact information for the supervisor at each location and can contact them immediately.

CCSO Crime Prevention deputies have been proactive about bringing awareness to this program and ensuring that construction companies take advantage of the resource. Deputies visit with contractors at offices, industry meetings and forums, and even on sites to distribute literature with program information. CCSO also educates the companies about trends and thefts in the construction industry. 

Through this program, the Sheriff's Office has developed an effective, long-lasting and significant strategy to reduce construction site thefts.

sam\u00ae home use treatment for knee pain
sam\u00ae home use treatment for knee pain

Sustained Acoustic Medicine (sam®) technology, the FDA-cleared ultrasound device created by ZetrOZ Systems, continues to demonstrate its ability to relieve pain and accelerate patients' return to sports, work and other daily activities. Now, medical professionals can administer the innovative technology as a pre- and post-treatment recovery option for regenerative medicine injectable treatments such as platelet-rich plasma (PRP) and other autologous cellular-based therapies.

PRP injections are safe, autologous blood products containing growth factors and cytokines with the potential to alter biological processes and support the three phases of tissue healing: inflammation, proliferation, and remodeling. PRP injections are commonly administered in the doctor's office multiple times over six to 12 months and may be painful to some patients. sam® offers a non-invasive, daily, home-use treatment option for pain and tissue remodeling, which is a powerful technology to complement PRP injections and other regenerative medicine therapies.

"Sustained acoustic medicine is a powerful mechanobiological treatment modality," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "Each treatment increases vessel diameter to boost blood flow over several hours, accelerating tissue healing and delivering a significant reduction in pain for patients. The use of ultrasound and shockwave treatment in the clinical setting to complement rehabilitation and regenerative medicine is broadly used. sam® is the first long-duration ultrasound treatment available for prescription home use."  

The use of sam® is also continuing to expand in the professional sports medicine market, with ongoing use by 75% of professional and college affiliations, including the NFL, NBA, MLS, WBNA, MLB and the ACC. ZetrOZ Systems also partners with all professional sports organizations and sports medicine providers in Atlanta, GA, and are proud supporters of the healthcare and athletic training societies of the NFL, MLB, NHL, NBA and MLS.

sam® treats over 35% of muscle and tendon injuries without surgery, helping elite athletes and professionals in physically demanding jobs get pain relief and natural healing. "Surgery is not always the best course of action for our athletes, and sam® technology offers a pathway to recovery without invasive surgery that can have risks and implications immediately or in the future," Lewis said.

Ultrasound therapy continues to show promise, with more than 40 peer-reviewed studies showing that sam® offers faster healing after injury or surgery. These findings can empower care providers to offer this easy-to-use regenerative device that leads to better outcomes, happier patients, and lowers healthcare system costs. The technology can serve as a standalone treatment or adjunct to other treatment options for patients to stimulate soft-tissue repair. 

To learn more, visit https://zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovation in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.

New West Dental Lab Introduces EndSnorZ\u2122 Sleep Appliance
New Mandibular Advancement Device Provides Dentists with an Innovative 3D-Printed Option to Treat Patients with Sleep Apnea

New West Dental Lab, a full-service dental laboratory that has been serving dentists nationally for over 40 years, has announced a new addition to its family of mandibular advancement devices (MADs), the EndSnorZ™ Sleep Appliance. Available exclusively from New West, the new appliance is a patient-specific device that is adjustable in 0.5 mm increments across a 10 mm range to treat snoring and obstructive sleep apnea (OSA). Dentists who trust New West with their crown & bridge restorations will find the EndSnorZ to be a reliable and precise 3D-printed appliance that fits well with the high-quality standards that the dental treatment of snoring and sleep apnea demands.

"I'm pleased to announce the availability of the EndSnorZ Sleep Appliance," said New West General Manager Hollie Taylor, CDT. "This device reflects our commitment to collaborating with our dentist customers and innovating the tools and techniques that help deliver the highest possible level of care for dental patients. The new EndSnorZ appliance builds on the latest cutting-edge CAD/CAM processes as well as 3D printing technologies to deliver an exceptional dental experience for both the clinician and patient."

The dental treatment of snoring and sleep apnea requires a trained dentist to position the jaw during sleep so that the tissues, muscles and ligaments of the upper airway have slight tension. This stops the vibration and partial airway collapse that creates the snoring sound. It also treats OSA by defending the airway from complete collapse.

All MADs, including the EndSnorZ, have a similar method of action. Upper and lower nightguards of the appliance have the same fit, form and function that dentists who treat snoring and sleep apnea are familiar with. The differences are in the orientation and material for the connector arms. EndSnorZ connector arms work through traction, gently pulling the jaw into position. This traction also tends to hold the mouth closed and prevents the jaw from collapsing during sleep, which would otherwise obstruct the airway. The EndSnorZ appliance encourages closed-mouth, quiet nasal breathing, increases patient comfort and provides a more restful sleep.

"Success in the practice of dental sleep medicine requires durable materials and precise, predictable fit, form and function," said Taylor. "The EndSnorZ appliance fills this requirement. Furthermore, it is affordably priced at $247 and it includes our standard two-year MAD warranty. This device provides many benefits for dentists interested in growing their practice with oral appliance therapy."

In its four decades of serving dentists across the country, New West Dental Lab has worked very closely with dental teams and vendor groups to provide an elevated patient experience. To learn more or to receive information about the appliance call 800-321-1614 or visit newwestlab.com/sleep.

Grow: The Clinical Advancement Platform

StaffGarden, the leader in software development supporting professional advancement programs such as clinical ladder programs that help nurses advance in their careers, is announcing a year-long partnership with the faith-based healthcare system AdventHealth. AdventHealth has more than 50 hospitals and hundreds of care sites in almost a dozen states, with 6.8 million patient interactions annually.

The clinical ladder is a structured system, traditionally on paper, to support nurses' career advancement while remaining in their current clinical setting, providing direct patient care.

Digitizing the clinical ladder in healthcare systems to promote nurse engagement has been overlooked in the industry. Grow, from StaffGarden, has stepped in and given nurses a better way to advance their careers by providing software that organizes materials in one centralized hub while tracking engagement. StaffGarden provides innovative technology solutions to over 800 facilities nationwide and will expand further in 2023.

"AdventHealth is an excellent partner to work with," Brian Card, StaffGarden's Vice President, said. "It's truly impressive to see our product impact the healthcare industry, helping nurses progress in their careers and assisting health systems with engagement and retention at such a critical time."

AdventHealth chose the StaffGarden Grow platform in early 2022 to launch its Professional Excellence Program across the system throughout 2022 and 2023. AdventHealth began with its direct care nurses and later expanded to a second program for assistant nurse managers.

"StaffGarden's platform has been integral to the successful launch of our national Nursing Professional Excellence Program. It supports the professional development needs of our nursing workforce. The platform is intuitive and makes it easy for our nurses to input the documentation supporting their work," said Trish Celano, Chief Nurse Executive for AdventHealth. "Also, the review and approval process for our nurse leaders is efficient." 

About StaffGarden

StaffGarden is the leading digital healthcare company in software development supporting Clinical Ladder, Competency Assessments, Peer Reviews, Magnet Tracking, and Portfolio Management in healthcare systems. StaffGarden is revolutionizing the way nurses track, share and manage their nursing careers. With seven years of experience, we are poised to take your clinical ladder to the next level. To learn more about StaffGarden, check us out on LinkedIn or at StaffGarden.com.

About AdventHealth

With a sacred mission of Extending the Healing Ministry of Christ, AdventHealth is a connected system of care for every stage of life and health. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies, and hospice centers provide individualized, wholistic care. A shared vision, common values, focus on whole-person health, and commitment to making communities healthier unify the system's more than 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states. For more information about AdventHealth, visit AdventHealth.com/news.

A person holding a Senzo Amplified Lateral Flow test.

Senzo, a life sciences company developing high accuracy, low-cost point-of-care diagnostic technologies, today announced a $1.9 million investment led by existing investors BioAdvance and Wellness Coaches.

The funding follows recent blinded studies by UCL and LateralDx, confirming that the Senzo Amplified Lateral Flow test had 98% accuracy in comparison to PCR in correctly identifying COVID-19 virus in samples, even at very low viral loads above 30 Ct. These studies, combined with an earlier study by Sheffield University, demonstrate the high performance of the Senzo Amplified Lateral Flow (ALF) platform. ALF is the only platform that combines the speed and low cost of lateral flow tests with the accuracy of PCR tests.

The investment will be used to complete validation, execute clinical trials, secure FDA EUA authorization, and scale manufacturing for the ALF COVID-19 test, as well as to advance R&D for new Flu A/B, RSV, Tuberculosis, HIV, Hepatitis-C, and Strep tests.

"This funding further indicates the interest and excitement investors have in the ALF platform, and is another important step in bringing our technology to market. Whether for COVID-19, TB, Flu, or a range of other diseases, there are patients in desperate need of better at-home, rapid-test diagnostics, and a huge market needing our tests. This investment will help us bring this innovative technology to market even faster," said Jeremy Stackawitz, CEO of Senzo Health.

Senzo plans to complete ALF COVID-19 clinical trials and secure FDA EUA regulatory approval in 1H 2023, with tests commercially available in the 2H 2023.

About Senzo:

Senzo is an in vitro diagnostics company developing innovative, accurate, and accessible testing products. Senzo was founded with the vision of utilizing novel technologies, with a focus on enhanced sensitivity, to create mobile, point-of-care and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing where healthcare professionals and patients need it most. Senzo is creating game-changing products and systems which bring testing to the patient, eliminating the need for the current slow, expensive central-lab testing paradigms.

About BioAdvance:

BioAdvance is an early-stage life sciences fund with a focus in the mid-Atlantic region, investing up to $1.5 million initially and up to $5 million over the lifetime of companies with the potential to significantly improve human health. www.bioadvance.com.

About Wellness Coaches:

Wellness Coaches is one of the largest and most-experienced tech-enabled wellness, nutrition, clinical, and injury prevention service providers, utilizing both onsite and virtual expertise to help communities and organizations increase engagement, improve population health, mitigate safety risks, and reduce healthcare and workers' compensation costs. www.wcusa.com. 

For more information, visit https://www.senzo.com.

Press Contact:
Alex Mohacs
[email protected]